<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04954651</url>
  </required_header>
  <id_info>
    <org_study_id>99-25/2/2021</org_study_id>
    <nct_id>NCT04954651</nct_id>
  </id_info>
  <brief_title>Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines</brief_title>
  <official_title>Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited&#xD;
      and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of&#xD;
      serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months&#xD;
      post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 7, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Antibody titer against Sars-Cov2</measure>
    <time_frame>0-9 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>SARS-CoV2 Infection</condition>
  <condition>Vaccine Reaction</condition>
  <arm_group>
    <arm_group_label>VAC</arm_group_label>
    <description>Vaccinated subject against Sars-Cov2</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Approved vaccines against Sars-Cov2</intervention_name>
    <description>Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU</description>
    <arm_group_label>VAC</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum from patients&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who voluntarily receive COVID-19 vaccines&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects who voluntarily receive COVID-19 vaccination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who do not complete their vaccination&#xD;
&#xD;
          -  Patients who do not provide info on their health status&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioannis Habeos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Patras</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioannis Habeos, MD, PhD</last_name>
    <phone>+306944966347</phone>
    <email>ihabeos@med.upatras.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natassa Parthymou, PhD</last_name>
      <phone>+302610969142</phone>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>July 6, 2021</last_update_submitted>
  <last_update_submitted_qc>July 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Patras</investigator_affiliation>
    <investigator_full_name>Ioannis Habeos</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sars-cov2</keyword>
  <keyword>vaccine</keyword>
  <keyword>age</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We plan to make the coded individual participant data available to other researchers upon reasonable request after the publication of the study in a journal</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

